Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors not yet approved by the MHRA or EMA for clinical use in the UK
You should continue using them, but you must let your health professional know if you are using any of the following: Ozempic / Wegovy (Semaglutide) Mounjaro (Tirzepatide) Trulicity (Dulaglutide) Victoza/Saxenda (Liraglutide) On the day of your surgery Your doctor will give you a specific time to stop eating and drinking
GLP-1 Series Part 3: Mounjaro driving largest declines in insulin usage Contact sales for details
You need not count every calorie forever, but understanding where protein comes from in your diet reveals gaps that require attention
If youve lost a significant amount of weight and you miss a birth control pill, it may have a greater effect on improving fertility than a missed pill would have on someone with a higher body weight
JAMA Intern Med 2024;184:1301-12.ArticlePubMedPMC 78